Skip to main content
SpringerLink
Log in

Chemotherapy of malignant gliomas: Comparison of the effect of polychemo- and CCNU-therapy

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Postoperative survival times of patients suffering from glioblastoma (astrozytoma III-IV) were compared in unselected groups receiving different forms of therapy: standard surgical therapy (16 cases, mean survival time 6.27±3.75 months), postoperative polychemotherapy (16 patients, survival time 8.96±4.97 months) or postoperative CCNU-monotherapy (24 cases, survival time 6.98±4.46 months). The mean survival time in the group receiving polychemotherapy was prolonged significantly when compared to the group with standard treatment. Survival time of the patient group treated with CCNU was not significantly increased. The results indicate that postoperative combination chemotherapy is more effective than CCNU monotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adrian, E. K., Walker, B. E., Incorporation of thymidine-H3 by cells in normal and injured mouse spinal cord. J. Neuropath. exp. Neurol.21 (1962), 597–609.

    PubMed  Google Scholar 

  • Armentrout, S. A., Foltz, E., Vermund, H., Otis, P. T., Comparison of postoperative irradiation alone and in combination with BCNU (NSC-409962) in the management of malignant gliomas. Cancer Chemother. Rep.58 (1974), 841–844.

    PubMed  Google Scholar 

  • Bering, E. A., Wilson, C. B., Norrell, H. A., The Kentucky Conference on brain tumour chemotherapy. J. Neurosurg.27 (1967), 1–10.

    PubMed  Google Scholar 

  • Bourke, R. S., West, Ch. R., Chheda, G., Tower, D. B., Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following intravenous injection in a primate. Cancer Res.33 (1973), 1735–1746.

    PubMed  Google Scholar 

  • Broder, L. E., Rall, D. P., Chemotherapy of brain tumours. Progr. exp. Tumor Res.17 (1972), 373–399.

    PubMed  Google Scholar 

  • Calogero, J., Crafts, D. C., Wilson, C. B., Boldrey, E. B., Rosenberg, A., Enot, K. J., Long-term survival of patients treated with BCNU for brain tumors. J. Neurosurg.43 (1975), 191–196.

    PubMed  Google Scholar 

  • Fewer, D., Wilson, C. B., Boldrey, E. B., Enot, K. J., Powell, M. R., The chemotherapy of brain tumours. Clinical experience with carmustine (BCNU) and vincristine. JAMA222 (1972), 549–552.

    PubMed  Google Scholar 

  • Gerstner, I., Jellinger, K., Heiss, W.-D., Wöber, G., Morphologic changes in anaplastic gliomes treated with radiation and chemotherapy. Acta Neurochir. (Wien)36 (1977), 117–138.

    Google Scholar 

  • Goldsmith, M. A., Carter, S. K., Glioblastoma multiforme — a review of therapy. Cancer treatment Reviews1 (1974), 153–165.

    Google Scholar 

  • Grunert, V., Jellinger, K., Sunder-Plassmann, M., Wöber, G., Glioblastoma multiforme: a preliminary follow up study. Modern Aspects of Neurosurgery3 (1975), 108–115.

    Google Scholar 

  • Handel, S. F., Powell, M. R., Wilson, C. B., Enot, K. J., Scintiphotographic evaluation of response of brain neoplasms to systemic chemotherapy. J. Nucl. Med.12 (1971), 292–296.

    PubMed  Google Scholar 

  • Hansen, H. H., Selawry, O. S., Muggia, F. M., Walker, M. D., Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-6-nitrosourea (NSC-79037). Cancer Res.31 (1971), 223–227.

    PubMed  Google Scholar 

  • Heiss, W.-D., Kroiss, A., Kühböck, J. Profanter, W., Kombinierte zytostatische Therapie maligner Hirntumoren. Münch. med. Wschr.116 (1974), 1957–1960.

    Google Scholar 

  • Hildebrand, J., Brihaye, J., Wagenknecht, L., Michel, J., Kens, Y., Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumours — a preliminary report. Europ. J. Cancer9 (1973), 627–634.

    Google Scholar 

  • Hoshino, T., Barker, M., Wilson, C. B., Boldrey, E. B., Fewer, D., Cell kinetics of human gliomas. J. Neurosurg.37 (1972), 15–26.

    PubMed  Google Scholar 

  • —, Wilson, C. B., Rosenblum, M. L., Barker, M., Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas. J. Neurosurg.43 (1975), 127–135.

    PubMed  Google Scholar 

  • Israel, L., Delohel, J., Scors, C., Bernard, E., Modalités et résultats des associations cytostatiques dans 218 cas de cancers avancés. 5. Internat. Congress of Chemotherapy Vienna 1967. Proceedings II/2.

  • Jelsma, R., Bucy, P. C., The treatment of glioblastoma multiforme of the brain. J. Neurosurg.27 (1967), 388–400.

    PubMed  Google Scholar 

  • Kernohan, J. W., Mabon, R. F., Svien, H. J., Adson, A. W., A simplified classification of gliomas. Proc. Mayo. Clin.24 (1949), 71–75.

    Google Scholar 

  • Krayenbühl, H., Anamnese und Klinik des Glioblastoma multiforma. Acta Neurochir. Suppl.6 (1959), 31–39.

    Google Scholar 

  • Oliverio, V. T., Kelly, M. G., Some preliminary observations on the physiological disposition, antitumour activity and carcinogenecity of a methyl hydrazine derivative. In: Chemotherapy of Cancer (Plattner, P. A., ed.), p. 221. Amsterdam: Elsevier. 1964.

    Google Scholar 

  • Rosenblum, M. L., Reynolds, A. F., Smith, K. A., Rumack, B. H., Walker, M. D., Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J. Neurosurg.39 (1973), 306–314.

    PubMed  Google Scholar 

  • Shapiro, W. R., Ausman, J. I., Rall, D. P., Studies on the chemotherapy of experimental brain tumours: Evaluation of 1,3-bis(2-chloroethyl)1-nitrosourea, cyclophosphamide, mithramycin and methotrexate. Cancer Res.30 (1970), 2401–2413.

    PubMed  Google Scholar 

  • Simon, G., Graul, E. H., Hundeshagen, H., Tracer-Studien mit radioaktiv markiertem Cyclophosphamid bei Hirntumoren. Acta Neurochir. (Wien)13 (1965), 441–455.

    Google Scholar 

  • Tator, C. H., Chemotherapy of brain tumours. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice. J. Neurosurg.37 (1972), 1–8.

    PubMed  Google Scholar 

  • Taveras, J. M., Clinical Neurosurgery, Vol. 7. Baltimore: Williams and Wilkins. 1961.

    Google Scholar 

  • Walker, M. D., Gehan, E. A., An evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and irradiation alone and in combination for the treatment of malignant gliomas. Proc. Amer. Ass. Cancer Res.13 (1972), 67.

    Google Scholar 

  • Walker, M. D., Hurwitz, B. S., BCNU (1,3-bis-2-chloroethyl-1-nitrosourea) (NSC-409962), in the treatment of malignant brain tumour. A preliminary report. Cancer Chemother. Rep.54 (1970), 263–271.

    PubMed  Google Scholar 

  • Willis, R. A., Pathology of Tumours. 3rd Ed. London: Butterworths Co. 1960.

    Google Scholar 

  • Wilson, C. B., Hoshino, T., Current trends in the chemotherapy of brain tumours with special reference to glioblastomas. J. Neurosurg.31 (1969), 589–603.

    PubMed  Google Scholar 

  • —, Boldrey, E. B., Enot, K. J., BCNU (1,3-bis[2-chloroethyl]-1-nitrosourea) in the treatment of brain tumours. Cancer Chemother. Rep.54 (1970), 273–281.

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. W. -D. Heiss

    Present address: Neurologische Universitätsklinik Wien, Austria

Authors and Affiliations

    Authors
    1. W. -D. Heiss
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Heiss, W.D. Chemotherapy of malignant gliomas: Comparison of the effect of polychemo- and CCNU-therapy. Acta neurochir 42, 109–115 (1978). https://doi.org/10.1007/BF01406637

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF01406637

    Keywords

    Search

    Navigation